Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Simmet

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Canadian Journal of Gastroenterology & Hepatology|February 19, 2021
A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular CarcinomaTorsten Diesinger, Alfred Lautwein, Sebastian Bergler, et al.
Plos One|July 24, 2020
Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitisTorsten Diesinger, Vyacheslav Buko, Alfred Lautwein, et al.
EMBO Molecular Medicine|March 23, 2019
Requirement for YAP1 signaling in myxoid liposarcomaMarcel Trautmann, Ya-Yun Cheng, Patrizia Jensen, et al.
The Journal of Biological Chemistry|September 5, 2013
Gremlin-1 is an inhibitor of macrophage migration inhibitory factor and attenuates atherosclerotic plaque growth in ApoE-/- MiceIris Müller, Tanja Schönberger, Martina Schneider, et al.
Nature Nanotechnology|January 22, 2013
Peptide nanofibrils boost retroviral gene transfer and provide a rapid means for concentrating virusesMaral Yolamanova, Christoph Meier, Alexey K Shaytan, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Canadian Journal of Gastroenterology & Hepatology|February 19, 2021
A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular CarcinomaTorsten Diesinger, Alfred Lautwein, Sebastian Bergler, et al.
Plos One|July 24, 2020
Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitisTorsten Diesinger, Vyacheslav Buko, Alfred Lautwein, et al.
EMBO Molecular Medicine|March 23, 2019
Requirement for YAP1 signaling in myxoid liposarcomaMarcel Trautmann, Ya-Yun Cheng, Patrizia Jensen, et al.
The Journal of Biological Chemistry|September 5, 2013
Gremlin-1 is an inhibitor of macrophage migration inhibitory factor and attenuates atherosclerotic plaque growth in ApoE-/- MiceIris Müller, Tanja Schönberger, Martina Schneider, et al.
Nature Nanotechnology|January 22, 2013
Peptide nanofibrils boost retroviral gene transfer and provide a rapid means for concentrating virusesMaral Yolamanova, Christoph Meier, Alexey K Shaytan, et al.
Pageof 14